Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Preservative exposure and surgical outcomes in glaucoma patients: The PESO study.

Boimer C, Birt CM.

J Glaucoma. 2013 Dec;22(9):730-5. doi: 10.1097/IJG.0b013e31825af67d.

PMID:
23524856
2.

Risk factors to develop ocular surface disease 
in treated glaucoma or ocular hypertension patients.

Rossi GC, Pasinetti GM, Scudeller L, Raimondi M, Lanteri S, Bianchi PE.

Eur J Ophthalmol. 2013 May-Jun;23(3):296-302. doi: 10.5301/ejo.5000220. Epub 2012 Dec 17.

PMID:
23335308
3.

Clinical audit examining the impact of benzalkonium chloride-free anti-glaucoma medications on patients with symptoms of ocular surface disease.

Goldberg I, Graham SL, Crowston JG, d'Mellow G; Australian and New Zealand Glaucoma Interest Group..

Clin Exp Ophthalmol. 2015 Apr;43(3):214-20. doi: 10.1111/ceo.12431. Epub 2014 Oct 2.

PMID:
25196488
4.

Long-term effect of BAK-free travoprost on ocular surface and intraocular pressure in glaucoma patients after transition from latanoprost.

Aihara M, Otani S, Kozaki J, Unoki K, Takeuchi M, Minami K, Miyata K.

J Glaucoma. 2012 Jan;21(1):60-4. doi: 10.1097/IJG.0b013e3181fc8129.

PMID:
21278589
5.

Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives.

Ramli N, Supramaniam G, Samsudin A, Juana A, Zahari M, Choo MM.

Optom Vis Sci. 2015 Sep;92(9):e222-6. doi: 10.1097/OPX.0000000000000542.

PMID:
25730335
6.

[Corneal sensitivity in patients treated medically for glaucoma or ocular hypertension].

Van Went C, Alalwani H, Brasnu E, Pham J, Hamard P, Baudouin C, Labbé A.

J Fr Ophtalmol. 2011 Dec;34(10):684-90. doi: 10.1016/j.jfo.2011.07.011. Epub 2011 Nov 16. French.

7.

Outcomes of combined cataract extraction, lens implantation, and trabeculectomy surgeries.

Rockwood EJ, Larive B, Hahn J.

Am J Ophthalmol. 2000 Dec;130(6):704-11.

PMID:
11124287
8.

Outcomes and bleb-related complications of trabeculectomy.

Jampel HD, Solus JF, Tracey PA, Gilbert DL, Loyd TL, Jefferys JL, Quigley HA.

Ophthalmology. 2012 Apr;119(4):712-22. doi: 10.1016/j.ophtha.2011.09.049. Epub 2012 Jan 14.

PMID:
22244944
9.

Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.

Ammar DA, Noecker RJ, Kahook MY.

Adv Ther. 2010 Nov;27(11):837-45. doi: 10.1007/s12325-010-0070-1. Epub 2010 Oct 7.

PMID:
20931366
10.

The Singapore 5-fluorouracil trial: intraocular pressure outcomes at 8 years.

Wong MH, Husain R, Ang BC, Gazzard G, Foster PJ, Htoon HM, Wong TT, Oen FT, Khaw PT, Seah SK, Aung T.

Ophthalmology. 2013 Jun;120(6):1127-34. doi: 10.1016/j.ophtha.2012.12.004. Epub 2013 Mar 1.

PMID:
23466269
11.

Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma.

Fontana H, Nouri-Mahdavi K, Lumba J, Ralli M, Caprioli J.

Ophthalmology. 2006 Jun;113(6):930-6. Epub 2006 Apr 27.

PMID:
16647135
12.

Efficacy and safety of preservative-free latanoprost eyedrops, compared with BAK-preserved latanoprost in patients with ocular hypertension or glaucoma.

Rouland JF, Traverso CE, Stalmans I, Fekih LE, Delval L, Renault D, Baudouin C; T2345 Study Group..

Br J Ophthalmol. 2013 Feb;97(2):196-200. doi: 10.1136/bjophthalmol-2012-302121. Epub 2012 Nov 30.

PMID:
23203707
13.

A twenty-year follow-up study of trabeculectomy: risk factors and outcomes.

Landers J, Martin K, Sarkies N, Bourne R, Watson P.

Ophthalmology. 2012 Apr;119(4):694-702. doi: 10.1016/j.ophtha.2011.09.043. Epub 2011 Dec 23.

PMID:
22196977
14.

Duration of IOP reduction with travoprost BAK-free solution.

Gross RL, Peace JH, Smith SE, Walters TR, Dubiner HB, Weiss MJ, Ochsner KI.

J Glaucoma. 2008 Apr-May;17(3):217-22. doi: 10.1097/IJG.0b013e31815a3472.

PMID:
18414108
15.

Surgical outcomes in childhood uveitic glaucoma.

Bohnsack BL, Freedman SF.

Am J Ophthalmol. 2013 Jan;155(1):134-42. doi: 10.1016/j.ajo.2012.07.008. Epub 2012 Oct 2.

PMID:
23036573
16.

Is intraocular pressure in the early postoperative period predictive of antimetabolite-augmented filtration surgery success?

Polikoff LA, Taglienti A, Chanis RA, Ramos-Esteban JC, Donas N, Tsong J, Gagliuso DJ, Danias J, Serle JB.

J Glaucoma. 2005 Dec;14(6):497-503.

PMID:
16276284
17.

Comparison of a travoprost BAK-free formulation preserved with polyquaternium-1 with BAK-preserved travoprost in ocular hypertension or open-angle glaucoma.

Gandolfi S, Paredes T, Goldberg I, Coote M, Wells A, Volksone L, Pillai MR, Stalmans I, Denis P; Travoprost Bak-Free Clinical Study Group..

Eur J Ophthalmol. 2012 Jan-Feb;22(1):34-44. doi: 10.5301/ejo.5000001.

PMID:
22167541
18.

Outcomes and complications of trabeculectomy enhanced with 5-fluorouracil in adults with glaucoma secondary to uveitis.

Chawla A, Mercieca K, Fenerty C, Jones NP.

J Glaucoma. 2013 Oct-Nov;22(8):663-6. doi: 10.1097/IJG.0b013e318255dc07.

PMID:
22706335
19.

Safety and Efficacy of Benzalkonium Chloride-optimized Tafluprost in Japanese Glaucoma Patients With Existing Superficial Punctate Keratitis.

Suzuki K, Teranishi S, Sagara T, Yoshino H, Nakayama M, Enoki M, Nuno Y, Hirano S, Wakuta M, Takahashi N, Tokuhisa K, Kondo Y, Shiraishi R, Ishida Y, Sonoda KH; Yamaguchi Glaucoma Study Group..

J Glaucoma. 2015 Aug;24(6):e145-50. doi: 10.1097/IJG.0000000000000020.

PMID:
24240881
20.

Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma.

Baudouin C.

Acta Ophthalmol. 2008 Nov;86(7):716-26. doi: 10.1111/j.1755-3768.2008.01250.x. Epub 2008 Jun 3. Review.

Supplemental Content

Support Center